Captix Biomedical Pty Ltd is an early stage medical technology company, founded to support the collaborative development and commercialisation of innovative technologies with the aim of delivering a cure for Type 1 (T1) diabetes that does not require life long immunosuppression.

Our website is currently in development. In the meantime, please use the form below to contact us with your questions or queries.

 

Contact us